Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin vs Doxepin in Uremic Pruritus
NCT03758079Phase 4
Key facts
- Status
- Completed
- Start
- Jun 2018
- Primary completion
- Oct 2018
- Countries
- 1
- Sponsor
- University of Balamand
- Modality
- Small Molecules
- Drugs
- gabapentindoxepin
- Conditions
- uremic pruritus
01
Overview
Phase 4, randomised, single-blind trial in uremic pruritus comparing Doxepin First with Gabapentin First (2 arms). Primary endpoints: Worst-itching Visual Analog Scale at 4 weeks, 5-D Itch Scale at 4 weeks and 1 more. Started Jun 2018; status: completed.
02
Design
2 arms- Study design
- RandomizedSingle-blind
Doxepin First
Patients receiving Doxepin first, then Gabapentin.
Gabapentin First
Patients receiving Gabapentin first, then Doxepin.
03
Who it enrols
Hemodialysis patients with uremic pruritus for at least 3 months, excluding those with fall risk, hepatic failure, heart failure, or other causes of pruritus.
04
Endpoints
Primary
Worst-itching Visual Analog Scale
5-D Itch Scale
Dermatology Life Quality Index
Secondary
Side effects of each treatment
Beyond the preview
Go deeper on NCT03758079.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03758079.